Northwest Biotherapeutics (NASDAQ: NWBO) reported Q3 EPS of ($0.35), versus ($0.65) reported last year. Revenue for the quarter came in at $582 thousand, versus $400 thousand reported last year.

For earnings history and earnings-related data on Northwest Biotherapeutics (NWBO) click here.